Back
Spyre Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
63
SYRE
Spyre Therapeutics, Inc.
Last Price:
$47.58
Seasonality Move:
-1.09%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and SYRE is experiencing slight buying pressure.
Spyre Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.88 | Buy |
| 20-day SMA: | 43.85 | Buy |
| 50-day SMA: | 39.64 | Buy |
| 200-day SMA: | 26.25 | Buy |
| 8-day EMA: | 46.92 | Buy |
| 20-day EMA: | 44.54 | Buy |
| 50-day EMA: | 40.51 | Buy |
| 200-day EMA: | 30.19 | Buy |
Spyre Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.39 | Buy |
| Relative Strength Index (14 RSI): | 60.73 | Buy |
| Chaikin Money Flow: | 101552 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.42 - 46.32) | Buy |
| Bollinger Bands (100): | (28.36 - 41.52) | Buy |
Spyre Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Spyre Therapeutics, Inc. Stock
Is Spyre Therapeutics, Inc. Stock a Buy?
-
Spyre Therapeutics, Inc. share price is 47.58 while SYRE 8-day simple moving average is 46.88, which is a Buy signal.
-
The stock price of SYRE is 47.58 while Spyre Therapeutics, Inc. 20-day SMA is 43.85, which makes it a Buy.
-
Spyre Therapeutics, Inc. 50-day simple moving average is 39.64 while SYRE share price is 47.58, making it a Buy technically.
-
SYRE stock price is 47.58 and Spyre Therapeutics, Inc. 200-day simple moving average is 26.25, creating a Buy signal.
SYRE Technical Analysis vs Fundamental Analysis
Buy
63
Spyre Therapeutics, Inc. (SYRE)
is a Buy
Is Spyre Therapeutics, Inc. a Buy or a Sell?
-
Spyre Therapeutics, Inc. stock is rated a BuyThe current Spyre Therapeutics, Inc. [SYRE] share price is $47.58. The Score for SYRE is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Spyre Therapeutics, Inc. Stock Info
Market Cap:
3.6B
Price in USD:
47.58
Share Volume:
438K
Spyre Therapeutics, Inc. 52-Week Range
52-Week High:
51.06
52-Week Low:
10.91
Buy
63
Spyre Therapeutics, Inc. (SYRE)
is a Buy
Spyre Therapeutics, Inc. Share Price Forecast
-
What is the Spyre Therapeutics, Inc. stock price today?The Spyre Therapeutics, Inc. stock price is 47.58 USD today.
-
Will SYRE stock go up or go down?Spyre Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Spyre Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Spyre Therapeutics, Inc. is not overvalued.
Is Spyre Therapeutics, Inc. Stock a Buy?
-
Spyre Therapeutics, Inc. share price is 47.58 while SYRE 8-day exponential moving average is 46.92, which is a Buy signal.
-
The stock price of SYRE is 47.58 while Spyre Therapeutics, Inc. 20-day EMA is 44.54, which makes it a Buy.
-
Spyre Therapeutics, Inc. 50-day exponential moving average is 40.51 while SYRE share price is 47.58, making it a Buy technically.
-
SYRE stock price is 47.58 and Spyre Therapeutics, Inc. 200-day simple moving average is 30.19, creating a Buy signal.
Fundamental Analysis of Spyre Therapeutics, Inc.
Is Spyre Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.51 per share, a decrease this year of $0.72 per share, and a decrease next year of $0.16 per share.
Technical Analysis of Spyre Therapeutics, Inc.
Should I short Spyre Therapeutics, Inc. stock?
-
SYRE Moving Average Covergence Divergence (MACD) indicator is 2.39, suggesting Spyre Therapeutics, Inc. is a Buy
-
Spyre Therapeutics, Inc. Relative Strength Index (RSI) is 60.73, which suggest Spyre Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Spyre Therapeutics, Inc. is (40.42 - 46.32), which suggest Spyre Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Spyre Therapeutics, Inc. is (28.36 - 41.52), which suggest Spyre Therapeutics, Inc. is a Buy
* Spyre Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.